Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-027803
Filing Date
2023-08-07
Accepted
2023-08-07 16:34:12
Documents
92
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q twst-20230630.htm   iXBRL 10-Q 1593173
2 EX-31.1 twst-20230630x10qxex311.htm EX-31.1 10615
3 EX-31.2 twst-20230630x10qxex312.htm EX-31.2 10641
4 EX-32.1 twst-20230630x10qxex321.htm EX-32.1 4848
5 EX-32.2 twst-20230630x10qxex322.htm EX-32.2 4846
11 10-Q twst-20230630_g1.jpg GRAPHIC 1195
  Complete submission text file 0001628280-23-027803.txt   8535333

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT twst-20230630.xsd EX-101.SCH 58228
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT twst-20230630_cal.xml EX-101.CAL 92551
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT twst-20230630_def.xml EX-101.DEF 289299
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT twst-20230630_lab.xml EX-101.LAB 810484
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT twst-20230630_pre.xml EX-101.PRE 534586
86 EXTRACTED XBRL INSTANCE DOCUMENT twst-20230630_htm.xml XML 1190758
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38720 | Film No.: 231148070
SIC: 2836 Biological Products, (No Diagnostic Substances)